PhRMA files lawsuit against Trump administration over GLOBE drug pricing demonstration program

PhRMA, the leading trade association for the pharmaceutical industry, has filed a lawsuit against the U.S. government challenging the Centers for Medicare & Medicaid Services' GLOBE drug pricing demonstration program.

The GLOBE initiative, finalized last week by the Trump administration, is a pilot effort intended to lower prescription drug costs by setting price caps for certain medicines covered by Medicare.

PhRMA argues that the program exceeds the agency's statutory authority and could disrupt market dynamics for innovative therapies.

The legal action underscores the industry's broader resistance to federal pricing controls and may shape future policy discussions on drug cost containment.